Ultrastructural and biochemical changes associated with pyrrolizidine-induced hepatic megalocytosis.
D000470:Alkaloids; D000818:Animals; D001653:Bile Ducts, Intrahepatic / Q000473:pathology; D002273:Carcinogens; D006528:Carcinoma, Hepatocellular / Q000473:pathology; D002462:Cell Membrane; D002467:Cell Nucleus; D056486:Chemical and Drug Induced Liver Injury; D003593:Cytoplasm; D004247:DNA / Q000096:biosynthesis; D004032:Diet; D004721:Endoplasmic Reticulum; D006056:Golgi Apparatus; D008099:Liver / Q000473:pathology*; D008107:Liver Diseases / Q000473:pathology; D008113:Liver Neoplasms / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D008930:Mitochondria, Liver; D012313:RNA / Q000096:biosynthesis; D051381:Rats
D000470:Alkaloids; D002273:Carcinogens; D012313:RNA; D004247:DNA